Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05735080
Title Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer (INX-315-01)
Acronym INX-315-01
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Incyclix Bio
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Emory Winship Cancer Institute RECRUITING Atlanta Georgia 30322 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Levine Cancer Institute (LCI)- Atrium Health RECRUITING Charlotte North Carolina 28204 United States Details
Duke Cancer Center/ DUMC RECRUITING Durham North Carolina 27705 United States Details
Gabrail Cancer Research Center RECRUITING Canton Ohio 44718 United States Details
Peter MacCallum Cancer Center RECRUITING Parkville Victoria 3052 Australia Details
Mater Hospital RECRUITING South Brisbane 4101 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field